Yellowstone Biosciences Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$21M
- Investors
-
2
Yellowstone Biosciences General Information
Description
Developer of a therapeutic biotechnology platform designed to create highly selective targeted therapies for cancer. The company offers proprietary access to a biobank for samples from acute myeloid leukemia patients, including a rare cohort of high-risk patients cured by allogeneic stem cell transplantation, enabling healthcare firms to identify frequently expressed peptide antigens presented by HLA Class II to transform patient lives.
Contact Information
Website
www.yellowstonebio.comCorporate Office
- 4100 Chancellor Court
- John Smith Drive, ARC Oxford
- Oxford OX4 2GX
- England, United Kingdom
Corporate Office
- 4100 Chancellor Court
- John Smith Drive, ARC Oxford
- Oxford OX4 2GX
- England, United Kingdom
Yellowstone Biosciences Timeline
Yellowstone Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 20-Jun-2024 | $21M | Completed | Startup | ||
| 1. University Spin-Out | 20-Jan-2023 | Completed | Startup |
Yellowstone Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Yellowstone Biosciences Comparisons
Industry
Financing
Details
Yellowstone Biosciences Competitors (28)
One of Yellowstone Biosciences’s 28 competitors is Exogene, a Venture Capital-Backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Exogene | Venture Capital-Backed | Oxford, United Kingdom | ||||
| TScan Therapeutics | Formerly VC-backed | Waltham, MA | ||||
| NextCure | Formerly VC-backed | Beltsville, MD | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| AVM Biotechnology | Private Equity-Backed | Seattle, WA |
Yellowstone Biosciences Signals
Yellowstone Biosciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Syncona | Venture Capital | Minority | ||
| University of Oxford | University | Minority |
Yellowstone Biosciences FAQs
-
When was Yellowstone Biosciences founded?
Yellowstone Biosciences was founded in 2023.
-
Where is Yellowstone Biosciences headquartered?
Yellowstone Biosciences is headquartered in Oxford, United Kingdom.
-
What is the size of Yellowstone Biosciences?
Yellowstone Biosciences has 29 total employees.
-
What industry is Yellowstone Biosciences in?
Yellowstone Biosciences’s primary industry is Discovery Tools (Healthcare).
-
Is Yellowstone Biosciences a private or public company?
Yellowstone Biosciences is a Private company.
-
What is the current valuation of Yellowstone Biosciences?
The current valuation of Yellowstone Biosciences is .
-
What is Yellowstone Biosciences’s current revenue?
The current revenue for Yellowstone Biosciences is .
-
How much funding has Yellowstone Biosciences raised over time?
Yellowstone Biosciences has raised $21M.
-
Who are Yellowstone Biosciences’s investors?
Syncona and University of Oxford have invested in Yellowstone Biosciences.
-
Who are Yellowstone Biosciences’s competitors?
Exogene, TScan Therapeutics, NextCure, Adaptimmune Therapeutics, and AVM Biotechnology are some of the 28 competitors of Yellowstone Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process